Class II

Drug Recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04.

Ajanta Pharma USA Inc · May 28, 2026

Reason for Recall

CGMP Deviations

Distribution

U.S. Nationwide

States Affected

NATIONWIDE

Quantity Affected

3648 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0611-2026

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.

Ajanta Pharma USA Inc Drug Recall: Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: Ajanta Pharma USA Inc. Bridgewater, NJ 08807, NDC 27241-120-04. | SafeCheck